← Open Payments lookup

NPI 1194318600: Open Payments

NPI 1194318600. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,561 in 59 payments from 16 companies in 2025. Trend: 2023 $922 · 2024 $1,388 · 2025 $1,561

Food & beverage: $1,379Education: $182
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.16$459
ABBVIE INC.6$196
Galderma Laboratories, L.P.6$181
SUN PHARMACEUTICAL INDUSTRIES INC.3$116
UCB, Inc.4$95
Amgen Inc.2$91
Janssen Biotech, Inc.4$73
Novartis Pharmaceuticals Corporation3$62
Organon LLC4$62
PFIZER INC.3$55

Products named: DUPIXENT, NEMLUVIO, RINVOQ, Bimzelx, TREMFYA, SKYRIZI, ADBRY, CIBINQO.